Is testosterone replacement therapy appropriate for patients with prostate cancer who have persistently low testosterone and associated symptoms, without signs of recurrence, and have a Gleason score of 4+4, treated with radiation and completed androgen deprivation therapy?
Year: 2026
Type: article
Abstract: No direct evidence for testosterone replacement therapy in high-risk prostate cancer survivors post-radiotherapy and ADT was found; limited indirect evidence suggests cautious consideration may be possible in some cases, with regular monitoring.
Author: Tripdatabase
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236719483
